Table 3.
Treatments | Assay | ||
---|---|---|---|
PCR | RT-PCR | ||
16S^ | ospC^ | 16S^ | |
Infected Untreated (OG) | 3/3 | 3/3 | 3/3 |
Infected Untreated (IP) | 5/5 | 5/5 | 5/5 |
Infected Untreated (SC) | 2/2 | 2/2 | 2/2 |
Azlocillin (IP) | 4/5 | 4/5 | 3/3 |
Bactrim (OG) | 5/5 | 5/5 | ND |
Disulfiram (OG) | 5/5 | 5/5 | ND |
Carbomycin (SC) | 5/5 | 5/5 | 5/5 |
Dapsone (OG) | 2/5 | 0/5 | 1/5 |
Rifampicin (OG) | 3/5 | 3/5 | 3/5 |
Cefotaxime (IP) | 2/5 | 0/5 | 1/5 |
Loratadine (OG) | 2/5 | 2/5 | 2/5 |
ND, Not done; OG, oral gavage; IP, intraperitoneal; SC, subcutaneous. ^ Number of mice positive for at least one tissue/total number of mice tested.